Regardless of whether you are a PvP player or a PvE player wanting to make an Arc build, this Destiny 2 Sidearm is a must ...

EMA committee recommends approval of Bristol Myers’ repotrectinib to treat advanced ROS1-positive NSCLC & NTRK-positive solid tumours: Princeton, New Jersey Monday, November 18, ...

A fusion reactor promises almost limitless energy—if we can build it. Physicist Tammy Ma explains how her team achieved ...

Boston Pharmaceuticals has linked its metabolic dysfunction-associated steatohepatitis (MASH) prospect to improved outcomes ...

Company remains on track in late-stage, potentially registrational trials of nemvaleukin alfa, with data readouts expected in late Q1/early Q2 ...

Tectonic Therapeutic to present positive phase 1a results of TX45, a long-acting, Fc-relaxin fusion protein at AHA 2024: Watertown, Massachusetts Tuesday, November 12, 2024, 13:00 ...

About TX45, a long-acting Fc-relaxin fusion protein TX45 is an Fc-relaxin fusion protein ... including the ongoing Phase 1b and Phase 2 clinical trials for TX45 in Group 2 PH-HFpEF; and the potential ...

Targeted therapy revolutionized cancer treatment, with gene fusions leading the way when the FDA approved imatinib in 2001 to ...

New hardware boasts significant improvements to reduce noise and generate higher fidelity signals ...

An integral part of a fusion power plant is its first wall, or the interior surface that faces the plasma during energy production. The strength and longevity of the first wall are key to the power ...